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Abstract: Oxidative and inflammatory stress have been implicated as major contributors 
to the aging process. Dietary Ca reduced both factors in short-term interventions, while 
milk exerted a greater effect than supplemental Ca. In this work, we examined the effects 
of life-long supplemental and dairy calcium on lifespan and life-span related biomarkers in 
aP2-agouti transgenic (model of diet-induced obesity) and wild-type mice fed obesigenic 
diets  until  their  death.  These  data  demonstrate  that  dairy  Ca  exerts  sustained  effects 
resulting in attenuated adiposity, protection against age-related muscle loss and reduction 
of oxidative and inflammatory stress in both mouse strains. Although these effects did not 
alter maximum lifespan, they did suppress early mortality in wild-type mice, but not in 
aP2-agouti transgenic mice. 
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1. Introduction  
 
Oxidative  stress  and  inflammatory  stress  have  been  implicated  as  a  cause  of  tissue  damage  in 
multiple  organ  systems  leading  to  the  development  of  chronic  diseases  such  as  obesity,  diabetes, 
hypertony and atherosclerosis [1-3]. They are also recognized as major factors contributing to the 
physiological process of aging [4,5]. Dietary calcium appears to play a significant role in regulating 
reactive oxygen species (ROS) production and inflammation in adipocytes  [6], and may therefore 
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contribute to a reduction of metabolic disorders and a prolonged lifespan. The major intracellular 
source of ROS production and free radicals in mammalian cells are mitochondria [7]. Under normal 
physiological  conditions,  mitochondria  generate  ROS  only  at  very  low  levels.  However,  several 
conditions, including obesity, hyperglycemia and hyperlipidemia can promote ROS production leading 
to oxidative damage to DNA, lipids and proteins. The resulting mitochondrial dysfunction can lead to 
increased ROS production with subsequent further damage and progressive decline of cellular and 
tissue functions due to energy depletion [7]. Supporting evidence shows a strong correlation between 
aging, increased mitochondrial ROS production and mitochondrial dysfunction [8-11]. In addition, 
inflammatory mediators such as tumor necrosis factor alpha (TNF-α) can induce oxidative stress by 
up-regulating NADPH oxidase and altering the mitochondrial redox state [12,13]. 
As  a  cellular  defense  against  oxidative  stress,  mammalian  cells  have  developed  an  array  of 
antioxidant  enzymes  and  proteins  to  dispose  ROS  under  normal  physiological  conditions.  These 
include superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase. However, the age 
associated decline of the enzyme activities coupled with an increase in intracellular ROS production 
can overwhelm the capacity of this defense system, resulting in increased oxidative stress [4,7,14]. 
Previous work from our laboratory has demonstrated an anti-obesity effect of calcium rich diets 
which  we  have  proposed  to  be  mediated,  in  part,  by  calcium  suppression  of  circulating  1α,25-
dihydroxyvitamin D (calcitriol) [15-17]. Calcitriol promotes glucocorticoid production in adipocytes, 
favoring  fat  storage  in  visceral  rather  than  subcutaneous  depots  [18].  Visceral  adiposity  is 
characterized  by  a  low-grade  systemic  inflammation  and  is  associated  with  the  development  of 
metabolic disorders [19]. Calcitriol also regulates ROS production by adipocytes [6]. Consequently, 
we  have  shown  that  suppression  of  calcitriol  by  dietary  calcium  inhibits  adipocyte-derived 
inflammatory  cytokine  expression  [20]  and  reduces  oxidative  stress  in  murine  and  human  
adipocytes [6,21]. We also demonstrated that dairy products exert greater effects than supplemental 
calcium, and have proposed that this increased effect is due to additional components in dairy such as 
branched-chain  amino  acids  (BCAA)  and  angiotensin  converting  enzyme  inhibitor  (ACEi)  
peptides [22,23].  
Considering the protective role of dietary calcium and other dairy components against oxidative and 
inflammatory stress, which otherwise accelerate the process of aging, the present study was designed 
to evaluate the effects of dietary calcium from both non-dairy and dairy sources on mouse lifespan and 
on  lifespan-related  biomarkers.  We  utilized  aP2-agouti  transgenic  mice  because  we  have  already 
demonstrated short-term effects of calcium on adiposity, oxidative stress and inflammatory stress in 
this model [6,20,23], and because these mice are susceptible to diet-induced obesity [24,30,31]. These 
mice express normal agouti protein under the control of the aP2 promoter in adipose tissue  [24], 
thereby mimicking the human pattern of agouti expression. They are not obese on a standard AIN93 G 
diet but develop mild to moderate obesity (25–40% increase in adipose tissue mass) when fed high 
sucrose/high fat diets for six to 12 weeks [24,30]. In order to gain a more complete understanding of 
the effect of this genotype, this study was also done in wild type littermates. 
 
   Nutrients 2009, 1                           
 
52 
2. Materials and Methods 
 
2.1. Animals and Diets 
 
Six to eight week old aP2-agouti mice of both genders (n = 197) and their littermate controls  
(n = 186) from our colony were randomly divided into three diet groups. Group 1 (control group) was 
fed a modified AIN93G diet with suboptimal calcium (calcium carbonate, 0.4%) and with sucrose as 
sole carbohydrate source, providing 64% of energy. Fat was increased to 25% of energy with lard. The 
sub-optimal level of calcium utilized for group 1 does not produce calcium deficiency, as it provides 
80% of the recommended level (0.5%) in mice. Instead, this calcium level results in a compensatory 
endocrine response, characterized by elevations in plasma calcitriol levels in order to prevent calcium 
deficiency symptoms [23]. Group 2 (high calcium group) and group 3 (milk group, NFDM) received 
the same diet as group 1, however modified to contain 1.2% calcium in form of calcium carbonate or 
to  contain  50%  of  protein  replaced  by  non-fat  dry  milk  with  1.2%  calcium,  respectively.  Diet 
composition is shown in Table 1.  
 
Table 1. Diet composition of the control, high calcium and non-fat dry milk (NFDM) diet groups. 
  Diet 
Control 
(0.4%) 
High Ca 
(1.2%) 
NFDM 
(1.2%) 
Ingredient (gm) 
Casein, 80 Mesh  160  160  0 
DL-Methionine  3  3  0 
Sucrose  637.9  638.3  429.7 
Cellulose  50  50  50 
Soybean oil  100  100  41.8 
Lard  10  10  65 
Mineral Mix S10022B  7  7  7 
Calcium carbonate  10  30  17.4 
Potassium phosphate, monobasic  8  8  8 
Potassium Citrate, 1 H2O  1.6  1.6  1.6 
Vitamin Mix V10037  10  10  10 
Choline Bitartrate  2.5  2.5  2.5 
t-Butylhydroqinone  0.014  0.014  0.014 
Milk, Nonfat, Dry  0  0  400 
Total  1000.014  1020.414  1033.014 Nutrients 2009, 1                           
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Table 1. Cont. 
Macronutrients (g/kgdiet) 
Protein  143.8  143.8  144.8 
Carbohydrate  647.9  648.3  647.7 
Fat  110.0  110.0  110.0 
Fiber  50  50  50 
Macronutrients (gm %) 
Protein  14.4  14.1  14.0 
Carbohydrate  64.8  63.5  62.7 
Fat  11.0  10.8  10.6 
Fiber  5.0  4.9  4.8 
Macronutrients (kcal/kg diet) 
Protein  575  575  579 
Carbohydrate  2592  2593  2591 
Fat  990  990  990 
Total  4157  4158  4160 
Macronutrients (kcal %) 
Protein  14  14  14 
Carbohydrate  62  62  62 
Fat  24  24  24 
Total  100  100  100 
Calcium, gm  4.03  12.03  12.03 
Phosphorus, gm  3.1  3.1  5.7 
Potassium, gm  3.61  3.61  10.81 
 
There  were  similar  numbers  of  both  genders  and  genotypes  in  each  group  (31 –35 
animals/subgroup). Three to four animals of the same gender and diet group were kept together in 
polypropylene cages at a room temperature of 22 ±  2 ° C and a regime of 12 h light/dark cycle until 
their  death.  The  animals  had  free  access  to  water  and  their  experimental  food  throughout  the 
experiment. All animals were checked daily for any signs of disease or death and moribund animals 
(as  defined  by  the  facility  veterinarian)  were  humanely  euthanized.  Weight  was  measured  to  the 
nearest gram at the beginning of the experiment and then at the beginning of each month until the 
death of the animals. Small subgroups (four males and four females) of each diet group and breed (48 
animals  per  age  group)  were  terminated  under  CO2  anesthesia  at  28,  52  and  78  weeks  of  age  to 
determine biochemical markers in adipose tissue, liver, muscle and blood. Blood was collected by 
cardiac  puncture.  The  excised  tissues  were  immediately  weighed  and  used  for  further  studies,  as 
described below. This study was approved from an ethical standpoint by the University of Tennessee 
Institutional Animal Care and Use Committee. 
 
 Nutrients 2009, 1                           
 
54 
2.2. Measurement of Blood Chemistry Markers 
 
Blood glucose  was determined in  whole  blood  by using a  glucometer. Insulin and adiponectin 
plasma levels were assessed by using Mouse Insulin and Adiponectin ELISA Kits, respectively (Linco 
Research, St. Charles, MO, USA). The levels of TNFα, IGF-I, IL6 and IL15 in plasma were measured 
by using the specific Mouse TiterZyme ELISA Kits from Assay Designs Inc. (Ann Arbor, MI, USA). 
Plasma  CRP  levels  were  calculated  by  using  the  Mouse  C-reactive  protein  ELISA  Kit  (Life 
Diagnostics, Inc., West Chester, PA, USA). MDA in plasma was assessed by using the TBARS Assay 
Kit (ZeptoMetrix Corporation, Buffalo, NY, USA).  
 
2.3. Measurement of Cortisol Release 
 
Perirenal fat tissue was incubated in KRB buffer for two hours. Cortisol release in the medium was 
determined by using the Cortisol Enzyme Immunoassay Kit from Assay Designs, Inc (Ann Arbor,  
MI, USA).  
 
2.4. Determination of Intracellular ROS Generation in White Adipose Tissue (Perirenal and Retro-
peritoneal Fat Pads) 
 
Adipose tissue (retroperitoneal and perirenal) digestion and adipocytes preparation was prepared as 
described in [Ca
2+]i measurement [6]. Adipose tissue was washed several times with Hank’s balanced 
salt solution, then minced into small pieces and digested with 0.8 mg/mL type I collagenase in a 
shaking water bath at 37° C for 30 min. Adipocytes were then filtered through sterile 500-μm nylon 
mesh  and  cultured  in  KRB  buffer  supplemented  with  1%  fetal  bovine  serum  (FBS).  Cells  were 
cultured  in  suspension  and  maintained  in  a  thin  layer at  the  top  of  culture  media  for  2h  for  cell 
recovery.  Intracellular  ROS  generation  was  assessed  by  using  6-carboxy-2’,7’-dichloro-
dihydrofluorescein  diacetate  (H2-DCFDA)  as  described  [25].  Cells  were  loaded  with  H2-DCFDA  
(2 μmol/L) for 30 minutes. After washing twice with KRB, Fluorescence (emission 520 nm) and 
protein  content  were  measured.  The  intensity  of  fluorescence  is  expressed  as  arbitrary  units  
per μg protein. 
 
2.5. Measurement of Enzyme Activities in Liver 
 
The  Superoxide  Dismutase  activity  (SOD)  was  measured  by  using  an  assay  kit  from  Cayman 
Chemical Company (Ann Arbor, MI, USA). Tissue samples were prepared according to manufacture’s 
instructions. Two hundred µ L of diluted radical detector (tetrazolium salt) was added to 10 µ L of 
sample or standard. The reaction was started by adding 20 µL  of diluted xanthine oxidase. After 20 
min of incubation the absorbance was read at 450 nm using a plate reader. One unit of SOD is defined 
as the amount of enzyme needed to exhibit 50 % dismutation of the superoxide radical. All three types 
of SODs (Cu/Zn-, Mn-, and Fe-SOD) were measured by the assay. 
The Catalase activity was measured as described [26]. Tissues were rinsed with phosphate buffered 
saline three times to remove any red blood cells, and then homogenized in 5–10 vol. of cold buffer  
(50  mM  potassium  phosphate,  pH  7.0).  1%  Triton  X-100  was  added  to  the  stock  homogenate  Nutrients 2009, 1                           
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(1:9) and then further diluted with phosphate buffer (1:200). The reaction was started by adding 1 mL 
H2O2 at 20° C to 2 ml homogenate. The decrease of absorbance at 240 nm against a blank (1 mL of 
phosphate buffer instead of substrate) was recorded for about 30s.  
The  Glutathione  peroxidase  (GPx)  activity  was  measured  using  an  assay  kit  from  Oxford 
Biomedical  Research  (Oxford,  MI,  USA).  Liver  tissue  was  prepared  according  to  manufacture’s 
instructions. Three hundred and fifty µ L of assay buffer, 350 µ L of NADPH Reagent and 70 µL of 
sample were pipetted into a cuvette. The reaction was started by adding 350 µ L of diluted tert-butyl 
hydroperoxide. The change in absorbance at 340 nm was recorded for three minutes. 
The NADPH oxidase activity was measured using the modified Quantitative Photometric Assay as 
described [27]. Freshly excised tissue was homogenized in 5 vol. of homogenization buffer (Krebs-
Ringer-Phosphate buffer containing 50 mM HEPES, 100 mM NaCl, 5 mM KCl, 1 mM MgCl2/H2O,  
1 mM NaH2PO4, 1 mM CaCl2, and 2 mM glucose, pH 7.4). Fifty µ L of sample was incubated with  
50 µ L of PBS and 50 µ L of phorbol myristate acetate (PMA) (1.625 µmol/L; Sigma Diagnostics) to 
initiate  the  respiratory  burst.  After  10  min  of  mixing,  50  µ L  of  nitroblue  tetrazolium  (NBT)  
(2.4 mmol/L; Sigma Diagnostics) was added to each individual well. The rate of NBT reduction was 
monitored at 490 nm for 30 min and optical density was recorded every 5 min by a photometer for 
microplates, starting immediately after the addition of NBT. The NADPH oxidase activity is expressed 
as the mean of absorbance (A) values in the 30-min period. 
AMPK  activity  was  measured  as  described  in  [28].  Freshly  excised  tissue  was  immediately 
homogenized in 2 vol. of homogenization buffer (50 mM Tris/HCL, 250 mM mannitol, 50 mM NaF,  
5  mM  sodium  pyrophosphate,  1  mM  EDTA,  1  mM  EGTA,  1  mM  DTT,  0.1  mM 
phenylmethylsulphonyl fluoride, 1 mM benzanidine, 1 μg/mL soybean trypsin inhibitor). Homogenate 
was centrifuged at 5,000 ×  g for 10 min and supernatant was aliquoted and stored at -80 ° C until 
further use. Reaction mixtures were prepared containing 5 µ L of 1 mM [γ-
32P] ATP, 5 µ L of 1 mM 
AMP in HEPES-Brij buffer, 5 µL of 1 mM SAMS peptide in HEPES-Brij buffer and 5 µ L of HEPES-
Brij  buffer.  The  reaction  was  initiated  by  the  addition  of  5  µ L  AMPK  sample.  After  30  min  of 
incubation at 30° C, 15 µ L was removed and spotted onto a P81 paper square. After washing the paper 
squares twice with 1% (v/v) phosphoric acid and once with acetone, they were laid out on a paper 
towel and allowed to dry. Dried filters were counted after immersing in 5 mL of scintillation cocktail. 
The  AMPK  activity  is  expressed  as  nanomoles  of  phosphate  incorporated  into  substrate  peptide  
per minute. 
 
2.6. Measurement of mRNA Expression 
 
Total RNA extraction: 
 
A total cellular RNA isolation kit (Ambion, Austin, TX, USA) was used to extract total RNA from 
abdominal  (inguinal  and  retroperitoneal)  fat  (three  animals/subgroup),  liver  and  soleus  muscle  
(four animals/subgroup) according to manufacturer’s instruction. The concentration, purity and quality 
of the isolated RNA were assessed by measuring the 260/280 ratio (1.7–2.1) and 260/230 ratio (close 
to 2.0) by using the ND-1000 Spectrophotometer (NanoDrop Technologies Inc., DE, USA). 
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Quantitative real time PCR: 
 
Gene expression of SOD (1 to 3), glutathione peroxidase, catalase, NADPH oxidase, TNFα, IL6, 
IL15,  UCP2,  UCP3,  adiponectin,  11β-HSD,  NFкB,  PPARα,  PPARγ,  PPARσ,  AMPK,  telomerase, 
Sirt1 and Sirt3 in retroperitoneal fat, soleus muscle and liver was quantitatively measured by using an 
ABI 7300 Real Time PCR System (Applied Biosystem, Branchburg, NJ, USA) with a TaqMan 1000 
Core Reagent Kit (Applied Biosystem). The primers and probes sets  were obtained from Applied 
Biosystems  TaqMan®  Gene  Expression  Assays  primers  and  probe  set  collection  according  to 
manufacturer’s instruction. Pooled adipocyte total  RNA  was serial-diluted and  used  to  establish a 
standard curve; total RNAs of unknown samples were also diluted in the same range. Reactions of 
quantitative RT-PCR for standards and unknown samples were performed according to the instructions 
of the ABI 7300 Real Time PCR System and TaqMan 1000 Core Reagent Kit (Applied Biosystem). 
Data for all transcripts were normalized to a housekeeping gene (18S) and are presented as a ratio of 
the transcript of interest to 18S.  
 
2.7. Statistical Analysis 
 
Data were evaluated by Multivariate Analysis of Variance (MANOVA) for statistically significant 
main effects of gender, genotype, diet and age and possible interactions between groups. Statistically 
significantly  different  means  in  subgroups  were  separated  by  the  least  significant  difference  test  
(p  ≤  0.05) using ANOVA. Data  points  were  identified  as outliers  graphically  with  box plots and 
removed when they were extreme (out of 3 IQ range). Survival analysis was done by using the Kaplan 
Meier survival analysis. All data analysis was done with SPSS software (SPSS inc., Chicago, IL, 
USA). Data are expressed as mean ±  standard error (SE).  
 
3. Results 
 
Because of the complex design of this experiment we used a MANOVA approach in the first step of 
analysis. This approach permits assessment of main effects of diets while holding the other factors 
(genotype, gender, age) constant as well as to identify interactions between factors. In cases where 
there  are  no  such  interactions,  this  provides  a  substantial  increase  in  effective  sample  size. 
Accordingly, the following section presents the main effects of diet on the combined subgroups, and 
only presents other main effects and interactions when statistically significant. 
 
Body weight and composition 
 
Figure 1 shows the mean of body weight for each subgroup over the study duration. Tables 2 and 3 
list the percentage of total body fat (calculated from the sum of abdominal, perirenal, subscapular and 
epididymal (in male mice) fat pads divided by body weight) and the percentage of muscle tissue 
(calculated from the sum of soleus and gastrocnemius muscle divided by body weight), respectively.  
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Males: 
 
Transgenic.  The  milk  diet  group  showed  a  lower  weight  compared  to  the  high  calcium  group 
continuously over the first year and to the control group starting at month 6. Although, no difference in 
weight was found between high calcium and control group, there was a significant reduction in adipose 
tissue mass (Table 2).  
 
Wild-type. The weight in the milk diet was continuously lower compared to the control and high 
calcium  diet  group.  This  difference  was  associated  with  a  reduction  in  adiposity (Table  2)  and  a 
prevention of muscle loss with age (Table 3) which was significantly different from the control group, 
but not the high calcium group. Although body weight in the high calcium group was not significantly 
different from the control group in the first year, it became statistically significant in the second year 
which  was  accompanied  by  a  significant  reduction  in  adiposity  and  a  prevention  of  muscle  loss 
compared to the control group at 78 weeks and 52 weeks of age, respectively. 
 
Figure 1. Mean weight distribution of all aP2-agouti transgenic and wild-type mice fed 
control, high calcium or NF DM diets over the study duration. Values are expressed as 
mean  ±   SE.  Letters  above  curve  denote  significant  differences  between  diet  groups,  
p < 0.05. 
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Table 2. Percentage of total body fat calculated from inguinal, retroperitoneal, perirenal, 
subscapular and epididymal (in male) fat pads per body weight in aP2-agouti transgenic 
and wild-type mice fed control, high calcium or NFDM diets at 28, 52 and 78 weeks of 
age. Values are expressed as mean ±  SE. Non-matching superscripts denote significant 
differences between diet groups, p < 0.05. 
   Diet 
control  high calcium  NFDM 
Gender  Genotype  Age  mean ±  SE  n  mean ±  SE  n  mean ±  SE  n 
female  wild  28 wk  6.53  ±   2.89  4  12.10  ±   1.57  4  9.24  ±   2.22  4 
52 wk  18.53  ±   2.18  4  14.37  ±   1.07  4  12.16  ±   3.07  4 
    78 wk  19.42  ±   1.49  3  17.84  ±   3.73  4  12.98  ±   1.44  3 
all  14.41  ±   2.26  11  14.77  ±   1.44  12  11.32  ±   1.39  11 
transgenic  28 wk  19.27  ±   1.69  4  16.90  ±   4.72  3  12.99  ±   0.65  4 
52 wk  19.24  ±   4.39  4  22.13  ±   1.15  4  16.52  ±   1.20  4 
78 wk  23.07  ±   2.94  5  23.84  ±   4.61  3  18.62  ±   3.33  4 
all  20.72  ±   1.76  13  21.07  ±   1.98  10  16.05  ±   1.29  12 
both    17.83  ±   1.53
 a  24  17.64  ±   1.36 
ab  22  13.79  ±   1.05 
b  23 
male  wild  28 wk  12.43  ±   0.87  4  12.73  ±   0.66  4  10.08  ±   0.75  4 
52 wk  15.33  ±   1.84  4  15.06  ±   0.19  4  13.65  ±   0.36  4 
78 wk  17.47  ±   1.96 
a  4  11.46  ±   2.05 
b  4  13.44  ±   1.11 
ab  4 
all  15.07  ±   1.05 
a  12  13.08  ±   0.79 
ab  12  12.39  ±   0.64 
b  12 
transgenic  28 wk  12.54  ±   1.11  4  12.38  ±   0.49  5  12.87  ±   0.94  4 
52 wk  16.67  ±   1.25 
a  3  12.88  ±   1.08
 b  4  13.18  ±   0.51 
b  4 
78 wk  19.97  ±   0.73  3  13.98  ±   4.94  3  13.56  ±   0.92  4 
all  16.00  ±   1.23 
a  10  12.94  ±   1.13 
b  12  13.20  ±   0.43
 ab  12 
both    15.50  ±   0.79 
a  22  13.02  ±   0.68
 ab  24  12.79  ±   0.39 
b  24 
both  wild  28 wk  9.48  ±   1.79  8  12.42  ±   0.79  8  9.66  ±   1.09  8 
52 wk  16.93  ±   1.46 
a  8  14.72  ±   0.52 
ab  8  12.91  ±   1.46 
b  8 
78 wk  18.30  ±   1.25 
a  7  14.62  ±   2.30 
ab  8  13.24  ±   0.84 
b  7 
all  14.76  ±   1.18 
a  23  13.93  ±   0.83 
ab  24  11.88  ±   0.74 
b  23 
transgenic  28 wk  15.90  ±   1.60  8  14.07  ±   1.78  8  12.93  ±   0.52  8 
52 wk  18.14  ±   2.42  7  17.50  ±   1.89  8  14.85  ±   0.87  8 
78 wk  21.90  ±   1.92  8  18.91  ±   3.74  6  16.09  ±   1.86  8 
all  18.67  ±   1.21 
a  23  16.64  ±   1.38 
ab  22  14.63  ±   0.73 
b  24 
both  28 wk  12.69  ±   1.42  16  13.24  ±   0.96  16  11.29  ±   0.72  16 
52 wk  17.49  ±   1.32 
a  15  16.11  ±   1.01 
ab  16  13.88  ±   0.86 
b  16 
78 wk  20.22  ±   1.24 
a  15  16.47  ±   2.07 
ab  14  14.76  ±   1.09 
b  15 
all  16.72  ±   0.88 
a  46  15.23  ±   0.81 
ab  46  13.28  ±   0.55
 b  47 
 
Table 3. Percentage of total muscle mass calculated from gastrocnemius and soleus muscle 
per body weight in aP2-agouti transgenic and wild-type mice fed control, high calcium or 
NFDM diets at 28, 52 and 78 weeks of age. Values are expressed as mean ±  SE. Non-
matching superscripts denote significant differences between diet groups, p < 0.05. 
   Diet 
control  high calcium  NFDM 
Gender  Genotype  Age  mean ±  SE  n   mean ±  SE  n  mean ±  SE  n 
female  wild  28 wk  0.33  ±   0.05  4  0.40  ±   0.04  4  0.32  ±   0.04  4 
52 wk  0.25  ±   0.04  4  0.28  ±   0.02  4  0.41  ±   0.09  4 
78 wk  0.35  ±   0.06  3  0.32  ±   0.05  4  0.36  ±   0.03  3 
all  0.31  ±   0.03  11  0.33  ±   0.02  12  0.36  ±   0.03  11 Nutrients 2009, 1                           
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Table 3. Cont. 
  transgenic  28 wk  0.28  ±   0.02  4  0.35  ±   0.10  3  0.38  ±   0.05  4 
52 wk  0.22  ±   0.02  4  0.24  ±   0.04  4  0.30  ±   0.04  4 
78 wk  0.18  ±   0.02  5  0.27  ±   0.08  3  0.33  ±   0.08  4 
all  0.22  ±   0.02 
a  13  0.28  ±   0.04
 ab  10  0.34  ±   0.33 
b  12 
both     0.26  ±   0.02 
a  24  0.31  ±   0.02 
ab  22  0.35  ±   0.02
 b  23 
male  wild  28 wk  0.29  ±   0.05  4  0.28  ±   0.05  4  0.43  ±   0.06  4 
52 wk  0.13  ±   0.01 
a  4  0.22  ±   0.03 
b  4  0.25  ±   0.03 
b  4 
78 wk  0.15  ±   0.05 
a  4  0.19  ±   0.04 
a  4  0.42  ±   0.05 
b  4 
all  0.19  ±   0.03 
a  12  0.23  ±   0.02 
ab  12  0.36  ±   0.04 
b  12 
transgenic  28 wk  0.23  ±   0.05  4  0.26  ±   0.02  5  0.23  ±   0.01  4 
52 wk  0.15  ±   0.02  3  0.16  ±   0.03  4  0.24  ±   0.03  4 
78 wk  0.19  ±   0.005  3  0.29  ±   0.04  3  0.23  ±   0.08  4 
all  0.19  ±   0.02  10  0.24  ±   0.02  12  0.24  ±   0.03  12 
both     0.19  ±   0.02 
a  22  0.23  ±   0.02 
ab  24  0.30  ±   0.03 
b  24 
both  wild  28 wk  0.31  ±   0.03  8  0.34  ±   0.04  8  0.38  ±   0.04  8 
52 wk  0.19  ±   0.03 
a  8  0.25  ±   0.02 
ab  8  0.33  ±   0.05 
b  8 
78 wk  0.24  ±   0.05 
a  7  0.25  ±   0.04 
a  8  0.39  ±   0.03 
b  7 
all  0.25  ±   0.024 
a  23  0.28  ±   0.02
 ab  24  0.36  ±   0.02 
b  23 
transgenic  28 wk  0.25  ±   0.02  8  0.29  ±   0.04  8  0.31  ±   0.04  8 
52 wk  0.19  ±   0.02 
a  7  0.20  ±   0.03 
ab  8  0.27  ±   0.03 
b  8 
78 wk  0.18  ±   0.01  8  0.28  ±   0.04  6  0.29  ±   0.06  8 
all  0.20  ±   0.01 
a  23  0.26  ±   0.02 
ab  22  0.29  ±   0.02 
b  24 
both  28 wk  0.28  ±   0.02  16  0.32  ±   0.03  16  0.34  ±   0.03  16 
52 wk  0.19  ±   0.02
 a  15  0.23  ±   0.02 
a  16  0.30  ±   0.03 
b  16 
78 wk  0.20  ±   0.02
 a  15  0.27  ±   0.03 
ab  14  0.34  ±   0.04 
b  15 
all  0.23  ±   0.01 
a  46  0.27  ±   0.01 
ab  46  0.33  ±   0.02
 b  47 
 
Females: 
 
Transgenic. The high calcium diet group exhibited the highest weight, and this difference reached 
statistical significance in older animals around 12 months of age. There was a trend for lower adiposity 
and higher percentage of muscle tissue in the milk diet group compared to the control diet group, 
however, it did not reach statistical significance. 
 
Wild-type. No difference in weight, fat mass and muscle mass was found among the diet groups. 
 
Summary: 
 
There was a significant gender–diet interaction reflected in a significant weight difference in the 
male mice for both genotypes in the milk diet group compared to control and high calcium diet group 
but not in female mice. Although there was a comparable trend towards reduced adiposity in females, 
it only becomes significant when the groups are combined. In addition, the milk diet prevented the 
increase  in  fat  mass  and  the  loss  in  muscle  mass  with  age  compared  to  the  control  group  when 
genotypes and genders were combined. Variation in weight evident in Figure 1 beginning at 24 months 
appear to be an artifact of the small number of surviving animals at that time point (1-3/group). 
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3.1. Oxidative stress 
 
ROS production (Figure 2). The age-related rise in ROS production was significantly blunted in the 
high calcium and milk diet groups compared to the control group. 
 
Figure  2.  ROS  production  (expressed  as  fluorescence  intensity/  μg  protein)  in  white 
adipose tissue (retroperitoneal and perirenal fat) in aP2-agouti transgenic and wild-type 
mice (gender and genotype combined) fed control, high calcium or NFDM diets at 28, 52 
and 78 weeks of age. Values are expressed as mean ±  SE, (n = 4–5). * Significant different 
from control, p < 0.05. 
 
GPx gene expression in soleus (Table 4). There were no diet interactions found; therefore data are 
collapsed for genotype, gender and age. The milk diet group had a significantly higher level of GPx 
gene expression than the control and high calcium diet groups. 
 
Table  4.  Glutathione  Peroxidase  (GPx)  (soleus  muscle)  and  Superoxide  Dismutase  3 
(SOD3)  gene  expression  (soleus  muscle  and  liver)  and  liver  SOD  enzyme  activity  of  
aP2-agouti transgenic and wild-type mice fed control, high calcium or NFDM diets (all 
three  age  groups  combined).  Gene  expression  data  are  normalized  to  18S  expression, 
enzyme activity to protein content. Values are expressed as mean ±  SE. Non-matching 
superscripts denote significant differences between diet groups, p < 0.05. 
   Diet 
control  high calcium  NFDM 
Gene 
expression  Gender  Genotype  mean ±  SE  n  mean ±  SE  n  mean ±  SE  n 
GPx soleus  female  wild   0.77  ±   0.06
 a  12  0.93  ±   0.90 
ab  12  1.06  ±   0.09 
b  12 
transgenic  0.81  ±   0.08 
a  12  0.84  ±   0.08 
a  11  1.20  ±   0.14 
b  12 
both  0.79  ±   0.05 
a  24  0.89  ±   0.06 
a  23  1.14  ±   0.08 
b  24 
male  wild  0.83  ±   0.07  11  0.74  ±   0.07  12  1.22  ±   0.20  12 
transgenic  0.83  ±   0.14  11  0.81  ±   0.10  13  0.82  ±   0.11  13 
both  0.83  ±   0.07  22  0.77  ±   0.06  25  1.01  ±   0.12  25 
both  wild   0.80  ±   0.05 
a  23  0.83  ±   0.06 
a  24  1.14  ±   0.10 
b  24 
both  transgenic  0.82  ±   0.08  23  0.83  ±   0.07  24  1.02  ±   0.10  25 
both  both  0.81  ±   0.04
 a  46  0.83  ±   0.05 
a  48  1.07  ±   0.07 
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Table 4. Cont. 
SOD 3 
soleus 
 
female  wild  0.73  ±   0.09 
a  12  0.88  ±   0.12 
a  12  1.31  ±   0.19 
b  12 
transgenic  0.81  ±   0.10  12  0.84  ±   0.13  11  0.88  ±   0.10  12 
both  0.77  ±   0.07 
a  24  0.86  ±   0.09 
ab  23  1.09  ±   0.12 
b  24 
male  wild   0.96  ±   0.08  11  0.90  ±   0.17  12  1.27  ±   0.26  12 
transgenic  0.80  ±   0.07  11  0.89  ±   0.09  13  0.85  ±   0.14  13 
both  0.88  ±   0.06  22  0.90  ±   0.10  25  1.06  ±   0.15  25 
both  wild   0.84  ±   0.07 
a  23  0.89  ±   0.11 
ab  24  1.30  ±   0.16
 b  24 
both  transgenic  0.81  ±   0.06  23  0.87  ±   0.08  24  0.87  ±   0.09  25 
both  both  0.82  ±   0.05  46  0.88  ±   0.07  48  1.07  ±   0.09  49 
SOD 3 liver  female  wild  0.48  ±   0.07  12  0.79  ±   0.22  12  0.86  ±   0.27  12 
transgenic  0.62  ±   0.11  12  0.52  ±   0.13  11  0.78  ±   0.26  12 
both  0.56  ±   0.07  24  0.66  ±   0.13  23  0.83  ±   0.19  24 
male  wild   0.48  ±   0.10  11  0.50  ±   0.12  12  0.97  ±   0.52  11 
transgenic  0.52  ±   0.13  11  0.38  ±   0.06  12  0.41  ±   0.08  13 
both  0.51  ±   0.08  22  0.44  ±   0.07  24  0.67  ±   0.25  24 
both  wild   0.49  ±   0.06  23  0.65  ±   0.13  24  0.92  ±   0.28  23 
both  transgenic  0.58  ±   0.09  23  0.45  ±   0.07  23  0.59  ±   0.14  25 
both  both  0.53  ±   0.05  46  0.55  ±   0.08  47  0.75  ±   0.15  48 
Enzyme activity 
SOD liver  female  wild  0.59  ±   0.07 
ab  12  0.35  ±   0.08 
a  12  0.83  ±   0.17 
b  12 
transgenic  0.55  ±   0.16  12  0.65  ±   0.14  11  0.63  ±   0.12  12 
both  0.57  ±   0.90  24  0.49  ±   0.08  23  0.73  ±   0.10  24 
male  wild   0.54  ±   0.16  11  0.48  ±   0.10  12  0.76  ±   0.18  11 
transgenic  0.34  ±   0.08  11  0.37  ±   0.07  12  0.59  ±   0.14  13 
both  0.44  ±   0.09  22  0.42  ±   0.06  24  0.68  ±   0.11  24 
both  wild   0.56  ±   0.09 
ab  23  0.42  ±   0.06 
a  24  0.79  ±   0.12 
b  23 
both  transgenic  0.45  ±   0.09  23  0.50  ±   0.08  23  0.61  ±   0.09  25 
both  both  0.50  ±   0.06 
a  46  0.46  ±   0.05 
a  47  0.70  ±   0.07 
b  48 
 
SOD3 gene expression in soleus (Table 4). There was a significant diet-genotype interaction. Wild 
type mice showed increased levels of SOD 3 expression in the milk diet group while no diet effect was 
found in the transgenic mice. 
 
SOD3 gene expression and enzyme activity in liver (Table 4). There were no diet interactions found; 
therefore only main effects of diet are reported. There was an overall increase in SOD enzyme activity 
in liver in the milk diet group compared to high calcium and control group; however, this was not 
associated with a significant difference in gene expression.  
 
Summary: 
 
The age-related rise in ROS production was significantly attenuated by calcium rich diets. This was 
associated in the milk diet group with an increase in GPx and SOD3 gene expression in soleus muscle 
as well as an increase in liver SOD enzyme activity. We also examined other markers such as Catalase 
and NADPH oxidase gene expression and liver activity, AMPK liver activity, and plasma MDA levels; 
however, no significant differences among the diet groups were found (data not shown). 
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3.2. Inflammatory Stress 
 
There was a statistically significant diet-gender interaction for adipocytokines (Table 5). Male mice 
showed  lower  levels  of  TNFα  and  IL6  gene  expression  in  abdominal  fat  tissue  in  the  milk  diet, 
consistent with previous data from our laboratory. Levels in females were quite low compared to males 
and were unaffected by diet. Cytokines and other markers in plasma were unchanged (data not shown). 
 
Table  5.  Gene  expression  of  IL6,  IL15,  TNFα  and  NFкB  in  inguinal  fat  tissue  in  
aP2-agouti transgenic and wild-type mice fed control, high calcium or NFDM diets (all 
three diet groups combined). Data are normalized to 18S expression. Values are expressed 
as  mean  ±   SE.  Non-matching  superscripts  denote  significant  differences  between  diet 
groups, p < 0.05. 
   Diet 
control  high calcium  NFDM 
Gene 
expression  Gender  Genotype  mean ±  SE  n  mean ±  SE  n  mean ±  SE  n 
IL 6  female  wild   0.21  ±   0.04  8  0.40  ±   0.13  8  0.42  ±   0.16  9 
transgenic  0.38  ±   0.08  11  0.38  ±   0.08  9  0.26  ±   0.32  8 
both  0.31  ±   0.05  19  0.39  ±   0.07  17  0.35  ±   0.08  17 
male  wild  1.45  ±   0.86  8  2.18  ±   0.67  10  0.57  ±   0.22  8 
transgenic  6.23  ±   2.12  8  2.87  ±   1.15  8  0.51  ±   0.07  9 
both  3.84  ±   1.27 
a  16  2.49  ±   0.62 
a  18  0.53  ±   0.48 
b  17 
both  wild   0.83  ±   0.44  16  1.39  ±   0.43  18  0.49  ±   0.13  17 
both  transgenic  2.85  ±   1.09  19  1.56  ±   0.61  17  0.39  ±   0.05  17 
both  both  1.93  ±   0.64  35  1.47  ±   0.36  35  0.44  ±   0.07  34 
TNF α  female  wild  0.33  ±   0.06  8  0.69  ±   0.30  8  0.24  ±   0.04  9 
transgenic  0.47  ±   0.08  11  0.68  ±   0.16  9  0.50  ±   0.16  9 
both  0.41  ±   0.05  19  0.69  ±   0.16  17  0.37  ±   0.08  18 
male  wild   1.49  ±   0.47  8  2.39  ±   0.39  10  0.73  ±   0.13  9 
transgenic  3.83  ±   0.74 
a  6  2.53  ±   0.64 
ab  9  1.17  ±   0.20 
b  9 
both  2.49  ±   0.51 
a  14  2.46  ±   0.35 
a  19  0.95  ±   0.13 
b  18 
both  wild   0.91  ±   0.27 
ab  16  1.64  ±   0.32 
a  18  0.49  ±   0.09 
b  18 
both  transgenic  1.65  ±   0.47  17  1.60  ±   0.39  18  0.84  ±   0.15  18 
both  both  1.29  ±   0.28  33  1.62  ±   0.25  36  0.66  ±   0.09  36 
IL 15  female  wild  0.43  ±   0.09  8  0.64  ±   0.14  8  0.69  ±   0.18  9 
transgenic  0.84  ±   0.19  11  0.88  ±   0.26  9  0.93  ±   0.27  9 
both  0.66  ±   0.13  19  0.77  ±   0.15  17  0.81  ±   0.16  18 
male  wild   0.85  ±   0.22 
a  7  1.45  ±   0.22 
b  10  0.61  ±   0.09 
a  9 
transgenic  1.18  ±   0.26  8  1.26  ±   0.31  9  1.07  ±   0.21  9 
both  1.02  ±   0.18  15  1.36  ±   0.18  19  0.84  ±   0.12  18 
total  wild   0.62  ±   0.12  15  1.09  ±   0.16  18  0.65  ±   0.10  18 
total  transgenic  0.98  ±   0.16  19  1.07  ±   0.20  18  1.00  ±   0.17  18 
total  total  0.82  ±   0.11  34  1.08  ±   0.13  36  0.83  ±   0.10  36 
NFкB  female  wild  0.84  ±   0.25  8  0.85  ±   0.20  8  0.72  ±   0.17  9 
transgenic  0.86  ±   0.17  11  0.96  ±   0.21  9  1.03  ±   0.23  9 
total  0.85  ±   0.14  19  0.91  ±   0.14  17  0.88  ±   0.15  18 
male  wild   1.27  ±   0.38  8  1.58  ±   0.22  10  0.83  ±   0.16  9 
transgenic  1.49  ±   0.47  7  1.09  ±   0.26  9  1.17  ±   0.22  9 
total  1.38  ±   0.29  15  1.35  ±   0.17  19  1.01  ±   0.14  18 
both  wild   1.05  ±   0.22  16  1.26  ±   0.17  18  0.77  ±   0.12  18 
both  transgenic  1.13  ±   0.23  18  1.03  ±   0.17  18  1.11  ±   0.16  18 
both  both  1.09  ±   0.16  34  1.14  ±   0.12  36  0.94  ±   0.10  36 
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3.3. Survival 
 
The survival analysis showed a longer lifespan in wild-type compared to transgenic mice for the 
milk  diet  group  (Figure  3B).  There  was  no  overall  diet  effect  on  maximal  lifespan  (Figure  3A), 
although the milk diet significantly reduced the early mortality rate in wild-type mice as demonstrated 
by a significant increase in 75% survival rate (Figure 3C). 
 
Figure 3. Survival curves of all aP2- agouti transgenic and wild-type mice fed control, 
high  calcium  or  NFDM  diets.  A:  Diet  effect  on  survival  independent  of  gender  and 
genotype.  B:  Genotype  effect  on  survival  independent  of  diet.  C:  Diet  effect  for  each 
genotype on survival. * Significant different, p < 0.05. 
 
3.4. Additional Findings 
 
Interestingly, we found a reduction of Sirt1 gene expression in abdominal fat (at 78 weeks) and in 
soleus muscle (Table 6). Also liver PPARα gene expression was reduced in the milk diet compared to 
the control group (Table 6). 
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Table 6. Sirt1 (inguinal fat and soleus muscle) and  PPARα (liver) gene expression in  
aP2-agouti transgenic and wild-type mice fed a control, high calcium or NFDM diet. Data 
are normalized to 18S expression. Values are expressed as  mean  ±  SE. Non-matching 
superscripts denote significant differences between diet groups, p < 0.05. 
   Diet 
control  high calcium  NFDM 
Gene 
expression  Gender  Genotype  Age  mean ±  SE  n  mean ±  SE  n  mean ±  SE  n 
Sirt1 
abdominal 
fat 
female  wild   all  0.88  ±   0.28  8  0.97  ±   0.17  8  0.82  ±   0.16  8 
transgenic  all  0.12  ±   0.22  11  1.28  ±   0.25  9  0.91  ±   0.21  9 
both  all  1.02  ±   0.17  19  1.13  ±   0.15  17  0.86  ±   0.13  17 
male  wild  all  1.17  ±   0.38 
a  8  1.43  ±   0.16 
b  10  0.77  ±   0.12 
a  9 
transgenic  all  1.28  ±   0.24  8  1.02  ±   0.25  9  1.10  ±   0.22  9 
both  all  1.23  ±   0.22  16  1.24  ±   0.15  19  0.94  ±   0.13  18 
both  wild   all  1.03  ±   0.23 
ab  16  1.23  ±   0.13 
b  18  0.79  ±   0.09
 a  17 
transgenic  all  1.19  ±   0.16  19  1.15  ±   0.17  18  1.00  ±   0.15  18 
both  28 wk  0.53  ±   0.10  12  0.66  ±   0.13  12  0.69  ±   0.16  11 
52 wk  0.87  ±   0.12 
ab  12  1.09  ±   0.12 
b  12  0.56  ±   0.08 
a  12 
78 wk  2.02  ±   0.19 
a  11  1.81  ±   0.11
 a  12  1.43  ±   0.08 
b  12 
both  both  all  1.12  ±   0.13  35  1.18  ±   0.11  36  0.90  ±   0.09  35 
Sirt1    
soleus 
female  wild  all  0.86  ±   0.12  11  1.02  ±   0.11  11  0.78  ±   0.08  12 
transgenic  all  1.07  ±   0.08 
a  11  0.86  ±   0.08 
ab  11  0.82  ±   0.08 
b  12 
both  all  0.97  ±   0.08  22  0.94  ±   0.07  22  0.80  ±   0.06  24 
male  wild   all  0.96  ±   0.07  10  1.13  ±   0.10  11  0.98  ±   0.13  11 
transgenic  all  0.98  ±   0.11  11  1.01  ±   0.10  11  0.78  ±   0.08  12 
both  all  0.97  ±   0.04 
ab  21  1.07  ±   0.07 
b  22  0.88  ±   0.08 
a  23 
both  wild   all  0.91  ±   0.07  22  1.07  ±   0.07  22  0.88  ±   0.08  23 
transgenic  all  1.03  ±   0.05 
a  21  0.94  ±   0.06 
ab  22  0.80  ±   0.05 
b  24 
both  28 wk  0.79  ±   0.05  14  0.76  ±   0.05  15  0.69  ±   0.06  15 
52 wk  1.04  ±   0.09 
ab  15  1.20  ±   0.10 
b  13  0.88  ±   0.07 
a  16 
78 wk  1.07  ±   0.06  14  1.07  ±   0.07  16  0.93  ±   0.10  16 
both  both  all  0.97  ±   0.04 
a  43  1.00  ±   0.05 
a  44  0.84  ±   0.05 
b  47 
PPAR α     
liver 
female  wild  all  0.62  ±   0.11  12  0.65  ±   0.13  12  0.70  ±   0.10  12 
transgenic  all  0.83  ±   0.14 
a  12  0.79  ±   0.14 
a  11  0.42  ±   0.07 
b  12 
both  all  0.73  ±   0.09  24  0.72  ±   0.10  23  0.56  ±   0.07  24 
male  wild   all  0.86  ±   0.18  11  0.40  ±   0.08  11  0.41  ±   0.08  11 
transgenic  all  0.86  ±   0.18  11  0.57  ±   0.11  12  0.56  ±   0.07  13 
both  all  0.86  ±   0.12 
a  22  0.49  ±   0.07 
b  23  0.49  ±   0.05 
b  24 
both  wild   all  0.74  ±   0.10  23  0.53  ±   0.08  23  0.56  ±   0.07  23 
transgenic  all  0.84  ±   0.11 
a  23  0.68  ±   0.09 
ab  23  0.49  ±   0.05 
b  25 
both  28 wk  0.88  ±   0.10 
a  15  0.57  ±   0.09 
b  16  0.56  ±   0.08
 b  17 
52 wk  0.47  ±   0.06  16  0.55  ±   0.11  15  0.45  ±   0.07  15 
78 wk  1.04  ±   0.17 
a  15  0.70  ±   0.12 
ab  15  0.56  ±   0.07
 b  16 
both  both  both  0.79  ±   0.08 
a  46  0.61  ±   0.06 
ab  46  0.53  ±   0.04 
b  48 
 
4. Discussion 
 
Our data demonstrate that age-related changes in body composition were blunted by calcium-rich 
diets. This is consistent with our previous short-term findings, which show that calcium-rich diets 
contribute to a reduction in body fat mass in both humans and mice under eucaloric and hypocaloric 
conditions [15,29-31]. We have also noted that dairy foods exert significantly greater effects than 
supplemental sources of calcium, and have attributed this observation to other bioactive components in 
dairy  products,  such  as  branched-chain  amino  acids  (BCAA)  and  angiotensin-converting  enzyme 
inhibitor (ACEi) peptides [32]. Leucine is well recognized to stimulate muscle protein synthesis, and Nutrients 2009, 1                           
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leucine  supplementation  decreases  age-related  loss  in  muscle  mass  in  both  rodents  and  
humans  [33-35].  Our  previous  data  also  indicate  that  leucine  alters  energy  partitioning  between 
adipose  tissue  and  muscle  by  augmenting  lipolysis  in  adipose  tissue  and  stimulating  fatty  acid 
oxidation in muscle to supply the energy demand of the anabolic process of protein synthesis [22]. 
Consistent with these observations, data from this study show a greater effect of the milk diet than of 
the high calcium diet in preventing the age-related increase in adiposity and the age-related loss of 
muscle mass.  
The free radical theory of aging, originally proposed by Harman [36], postulates that the aging 
process  is  caused  by  accumulation  of  free  radicals  over  time,  resulting  in  oxidative  damage  and 
progressive deterioration of biological systems. Since mitochondria are the major production site of 
free radicals, this theory was extended to the mitochondrial theory of aging [37], which proposes that 
cumulative oxidative damage to mtDNA leads to a decline in bioenergetic function of mitochondria 
with a progressive decline of cellular and tissue functions. Other major sources of oxidative stress are 
ROS generating enzymes such as calcium-dependent NADPH oxidase which plays a crucial role in 
developing vascular diseases [38]. Furthermore, there is bidirectional interaction between intracellular 
calcium  signaling  and  ROS  with  calcium  activating  ROS  production  by  cellular  enzymes  and 
mitochondria,  and  ROS  increasing  intracellular  calcium  levels  by  activating  calcium  channels  on 
plasma membrane and endoplasmatic reticulum [39,40]. Accordingly, our previous data demonstrate 
that decreasing intracellular [Ca
2+] by dietary calcium can diminish ROS production, as increasing 
dietary  calcium  suppresses  circulating  calcitriol,  which  otherwise  increases  intracellular  [Ca
2+]i  in 
multiple cell types [16,17].  
We have shown that suppression of calcitriol results in an inhibition of cellular NADPH oxidase 
gene expression [6], and in an increase in UCP production which diminishes mitochondrial membrane 
potential,  thereby  resulting  in  decreased  ROS  production  [41].  In  addition,  dairy  products  further 
enhances this anti-oxidant effect [23], most likely mediated by the inhibition of the local adipocyte 
renin-angiotensin-system (RAS) by ACEi peptides in dairy products [42-44]. Data from this long-term 
study also demonstrate that dietary calcium significantly reduced the age-related rise in ROS, and that 
dairy exerted a greater effect than calcium carbonate. However, in contrast with our previous data, this 
reduction was not found in younger mice (28 weeks old) and was not associated with alterations of 
NADPH oxidase and UCP expression. Instead, we found an increase in antioxidant enzyme activity 
and associated gene expression in the milk diet. Since aging is associated with a decline in anti-oxidant 
enzyme activity [14,45], our observation that dairy components appear to attenuate this decline is 
likely to play a role in reducing ROS formation with aging.  
Oxidative  stress  can  cause  a  dysregulation  of  adipocytokines  [2,46],  and  data  from  this  study 
indicate that this effect is attenuated by high calcium diets, as demonstrated by decreases in adipose 
tissue TNFα and IL6 expression. Consistent with this, we previously demonstrated that calcitriol can 
stimulate inflammatory cytokine expression in human and murine adipocytes [20] and that suppression 
of calcitriol by high calcium diets attenuates the inflammatory response in shorter-term studies [23]. 
An  additional  reduction  is  seen  with  dairy  products;  this  is  most  likely  mediated  by  ACEi  
peptides [47].  
There  was  a  significant  gender-diet  interaction  for  body  weight  and  abdominal  adipocytokine 
production. The  milk diet  significantly reduced body weight  gain over  the first year and  reduced Nutrients 2009, 1                           
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expression of TNFα and IL6 in visceral abdominal fat in male mice, while these effects were not found 
in  females.  Multiple  studies  have  shown  that  sex  hormones  are  responsible  for  gender  specific 
differences  in  fat  distribution  and  adipose  metabolism  [48,49].  Premenopausal  females  tend  to 
accumulate fat in non-visceral areas such as hip and thighs while men develop visceral adiposity with a 
higher risk for metabolic disorders, as visceral fat is the major production site of adipocytokines [50-52]. 
Moreover,  estrogens  can  cause  an  anti-inflammatory  effect  with  inhibition  of  TNFα  and  IL6  in 
macrophages [53,54]. We have demonstrated that the response of visceral fat to dietary calcium is 
higher  than  that  of  subcutaneous  fat  [20].  In  support  of  these  concepts,  the  male  mice  showed 
markedly higher levels of adipocytokines compared to females.  
Since oxidative and inflammatory stress is a major contributor to aging, we hypothesized that a 
reduction of both by dietary calcium could influence the lifespan in mice. In support of this hypothesis, 
studies in short-lived animals such as nematodes and flies have shown that a reduction in oxidative 
stress increased the lifespan [55-57]. In addition, the senescence accelerated mouse (SAM) model is 
associated with many characteristic features of mammalian aging, increased oxidative stress and a 
shortened lifespan [58], and administration of a free radical scavenger prolonged the lifespan in this 
model [59]. On the other hand, modifying the antioxidant defense system resulted in contradicting 
findings  in  some  models  of  aging.  While  over-expression  of  catalase  in  mice  extended  the  life  
span [60,61], a reduction in SOD activity increased oxidative stress and cancer incidence but did not 
accelerate aging in mice [62]. Although the age-related increase of oxidative stress was reduced by the 
milk diet in our animals, we did not find any overall diet effect on mean and  maximal survival; 
however,  the  milk  diet  decreased  the  early  mortality  in  wild-type  mice,  as  demonstrated  by  a 
significant increase in 75% survival rate. At this point, it is not clear why this effect is seen only in the 
wild-type mice. Since the agouti transgene is only locally expressed in adipose tissue, no systemic 
alterations  were  expected.  However,  the  survival  analysis  revealed  a  shorter  survival  rate  of  the 
transgenic mice compared to the wild-type mice in the milk diet group. Therefore, it is possible that 
this overall genotype effect could have overwhelmed any possible diet interaction. 
Interestingly, we found a decrease of sirtuin 1 (Sirt1) gene expression in abdominal adipose tissue 
and soleus muscle as well as a reduction of peroxisome proliferation activating receptor (PPAR) α 
gene  expression  in  liver  in  the  milk  diet  group.  The  sirtuins  belong  to  a  conserved  family  of 
deacetylases and have been linked to prevention of mitochondrial dysfunction, aging and metabolic 
disease  [63,64].  In  addition,  the  NAD+-dependent  histone  deacetylase  Sirt1  regulates  energy 
metabolism  such  as  glucose  homeostasis  and  fat  metabolism  [65].  PPARα,  a  ligand-activated 
transcription factor and mainly expressed in muscle and liver, is also involved in lipid metabolism and 
inflammation  [66].  At  this  point,  it  is  not  clear  how  to  interpret  these  findings,  especially  in  the 
absence of data from other members of the sirtuin family. We speculate that the overall reduction in 
adiposity, oxidative and inflammatory stress by the milk diet acts as a negative feedback loop and 
counteracts Sirt1 and PPARα up-regulation. 
In  conclusion,  data  from  the  present  study  demonstrate  that  life-long  feeding  of  a  milk  diet 
attenuates adiposity under eucaloric conditions and protects against age-related muscle loss. Consistent 
with  previous  findings,  we  show  that  dietary  calcium  reduces  oxidative  and  inflammatory  stress. 
Although these effects did not influence the maximum lifespan, they did suppress early mortality. 
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